Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vectors for expression of prostate-associated antigens

Vectors for expression of prostate-associated antigens

US Patent 11173196 · Granted Nov 16, 2021

Estimated economic value: $1,855,327,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant vaccinia virus and methods of use thereof2022
Prostate-associated antigens and vaccine-based immunotherapy regimens2021
Cancer vaccines2021
Cancer vaccines2019
Vectors for expression of prostate-associated antigens2018
Prostate-associated antigens and vaccine-based immunotherapy regimens2016
Vectors for expression of prostate-associated antigens2016
Prostate-associated antigens and vaccine-based immunotherapy regimens2015